Concepedia

Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis

Courtney Perry, Kyle B. Fischer, Ahmed Elmoursi, Cody Kern, Alden Currier, Praneeth Kudaravalli, Olalekan Akanbi, Nishant Tripathi, Pradeep Yarra, Leon Su,

Digestive Diseases and Sciences · 2020 · 28 citations · 14 references

DOI

Concepts

References

14

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

, , +14

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine · 2010 · 3.1K citations · Full text

, , +14

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

, , +15

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

Jean‐Frédéric Colombel, Paul Rutgeerts, Walter Reinisch et al. · Gastroenterology · 2011 · 919 citations · Full text

, , +16

The safety of vedolizumab for ulcerative colitis and Crohn's disease

Jean‐Frédéric Colombel, Bruce E. Sands, Paul Rutgeerts et al. · Gut · 2016 · 803 citations · Full text

, , +10